UKCA and UK MDR 2002: Selling into Great Britain

Placing a medical device on the Great Britain market means working with two names that buyers hear constantly and rarely see explained together: UKCA marking and the UK MDR 2002. UKCA stands for UK Conformity Assessed, and it is the product marking for the Great Britain market. The UK MDR 2002 is the law behind it, the Medical Devices Regulations 2002, which still governs devices in Great Britain after the EU medical device regulation took over in Europe. This guide sets out, from the MHRA’s own guidance, which marking your device needs, how long CE marking remains acceptable, and what registration requires before the first unit sells.

The rules differ by market, by device class, and by the certificates a device already holds, so the first step is a clear picture of the current framework rather than a guess based on how the EU system works.

The UK MDR 2002: The Law That Still Applies

Devices are regulated in Great Britain under the Medical Devices Regulations 2002, published as SI 2002 No 618 and amended over the years, which the MHRA refers to as the UK MDR 2002. Before the end of the Brexit transition period, those regulations gave effect in UK law to the EU directives for active implantable medical devices (AIMDD), general medical devices (MDD), and in vitro diagnostic devices (IVDD). The EU MDR and the EU IVDR, which replaced those directives in Europe, are not retained legislation in Great Britain.

The practical consequence is that the classification rules and conformity assessment routes a British buyer sees on a certificate may be based on the older directive framework rather than the EU MDR, and both frameworks coexist during the transition. The official text of the Medical Devices Regulations 2002 is on the legislation.gov.uk site, and the MHRA’s regulating medical devices in the UK guidance is the reference point for every requirement below.

UKCA Marking: What It Is and Who Needs It

The UKCA marking is the UK product marking used for medical devices placed on the Great Britain market. It is not recognised in the EU, the EEA, or Northern Ireland, so a UKCA mark alone does not open those markets. Where the rules require third-party conformity assessment for UKCA, a UK approved body must carry it out, and UK approved bodies cannot issue CE certificates.

Not every device needs a UK approved body. Non-sterile, non-measuring Class I devices and general in vitro diagnostics can be self-certified against the UK MDR 2002 requirements, while Class I devices that are sterile or have a measuring function need a UK approved body. The decision tree is the same shape as the EU framework the regulations were built from, which makes the classification check the first step for any manufacturer deciding between UKCA, CE, or both. The EU MDR device classification guide explains the class definitions that carry over into the UK system.

CE Marking Is Still Accepted in Great Britain

For most devices, UKCA is an option, not a requirement, because the MHRA continues to accept CE-marked devices on the Great Britain market. The acceptance window depends on the device type and the EU legislation the device complies with:

Mandatory third-party CE assessment must come from an EU notified body, and those certificates remain valid for the Great Britain market within the windows above. The government has also announced that it will consult on indefinite recognition of CE-marked medical devices, which means the dates above are the current position, not necessarily the permanent one. Buyers should treat the marking date and the certificate expiry date on every unit as a compliance item, because a device whose certificate lapses can lose its legal route to the GB market.

Northern Ireland and the UKNI Marking

Northern Ireland follows a different set of rules, and a GB-focused plan that ignores it creates a gap for distributors covering the whole UK. CE marking is required for the Northern Ireland market, and the UKNI indication is also required when a UK notified body carries out the mandatory third-party conformity assessment. The EU MDR has applied in Northern Ireland since 26 May 2021, so devices sold there sit under the EU framework rather than the UK MDR 2002. A device with UKCA marking alone cannot be placed in Northern Ireland, and the UKNI indication cannot be used on devices placed on the GB market.

MHRA Registration and the UK Responsible Person

All medical devices, including IVDs, custom-made devices, and systems or procedure packs, must be registered before they are placed on the Great Britain market. The MHRA accepts registration only from manufacturers based in the UK, so an overseas manufacturer must appoint a UK Responsible Person to handle the registration and the associated duties: keeping technical documentation available, cooperating with the MHRA, reporting complaints to the manufacturer, and ending the relationship if the manufacturer breaches its obligations.

Failure to register means the device cannot lawfully be placed on the Great Britain market, so the registration status is a due-diligence item for every buyer and distributor, not just for manufacturers. The CE marking step-by-step guide covers the conformity assessment documentation that registration builds on, and the CE vs ISO 13485 guide explains how the quality system certificate relates to the product certificate.

What This Means for Buyers and Distributors

For a buyer or distributor placing imported devices into Great Britain, three checks settle most of the risk. First, confirm the marking on the device and its packaging: CE, UKCA, or CE plus UKNI depending on the target market. Second, check the certificate expiry date against the MHRA acceptance windows, because a device cleared for the EU market with an expiring MDD certificate has a finite GB horizon. Third, confirm the UK Responsible Person and the MHRA registration number before payment, since registration is a precondition for lawful placement.

The technical file behind the marking is the same document set a customs broker and a hospital’s procurement team will ask for: the Declaration of Conformity, the test reports, and the registration confirmation. Keeping those three documents in one pack removes most of the friction at the border and at the hospital gate.

Suppliers that handle both EU and GB routes typically ship the same device with the same technical file, and the documentation package is where the Sanyang programme OEM/ODM et de localisation adds the compliance paperwork, registration support, and labeling for the target market. The UK market is open through CE recognition today, with UKCA as the GB-native route and the future framework still being shaped, which is exactly why the marking check belongs in the procurement checklist rather than the customs process.